CRNXCrinetics Pharmaceuticals, Inc.May 8, 2026Q1 2026
Read transcript →Crinetics Pharmaceuticals, Inc. (CRNX) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$35.42
+1.23%
Mkt Cap $3.54B
CRNXCrinetics Pharmaceuticals, Inc.May 8, 2026CRNXCrinetics Pharmaceuticals, Inc.Feb 26, 2026Q4 2025
Read transcript →CRNXCrinetics Pharmaceuticals, Inc.Nov 7, 2025Q3 2025
Read transcript →CRNXCrinetics Pharmaceuticals, Inc.Aug 9, 2025Q2 2025
Read transcript →CRNXCrinetics Pharmaceuticals, Inc.May 8, 2025Q1 2025
Read transcript →CRNXCrinetics Pharmaceuticals, Inc.Feb 28, 2025Q4 2024
Read transcript →CRNXCrinetics Pharmaceuticals, Inc.Nov 12, 2024Q3 2024
Read transcript →CRNXCrinetics Pharmaceuticals, Inc.Aug 8, 2024Q2 2024
Read transcript →CRNXCrinetics Pharmaceuticals, Inc.May 9, 2024Q1 2024
Read transcript →CRNXCrinetics Pharmaceuticals, Inc.Feb 29, 2024Q4 2023
Read transcript →CRNXCrinetics Pharmaceuticals, Inc.Mar 30, 2021Q4 2020
Read transcript →